benevolentai bio limited
benevolentai bio limited Company Information
Company Number
08774096
Next Accounts
Sep 2025
Shareholders
benevolentai limited
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
4-8 maple street, london, W1T 5HD
Website
benevolent.com/contact-usbenevolentai bio limited Estimated Valuation
Pomanda estimates the enterprise value of BENEVOLENTAI BIO LIMITED at £8.1m based on a Turnover of £8.7m and 0.92x industry multiple (adjusted for size and gross margin).
benevolentai bio limited Estimated Valuation
Pomanda estimates the enterprise value of BENEVOLENTAI BIO LIMITED at £0 based on an EBITDA of £-21.9m and a 6.62x industry multiple (adjusted for size and gross margin).
benevolentai bio limited Estimated Valuation
Pomanda estimates the enterprise value of BENEVOLENTAI BIO LIMITED at £0 based on Net Assets of £-55.8m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Benevolentai Bio Limited Overview
Benevolentai Bio Limited is a live company located in london, W1T 5HD with a Companies House number of 08774096. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in November 2013, it's largest shareholder is benevolentai limited with a 100% stake. Benevolentai Bio Limited is a established, mid sized company, Pomanda has estimated its turnover at £8.7m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Benevolentai Bio Limited Health Check
Pomanda's financial health check has awarded Benevolentai Bio Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
0 Regular
6 Weak
Size
annual sales of £8.7m, make it larger than the average company (£2.9m)
£8.7m - Benevolentai Bio Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 5%, show it is growing at a slower rate (7.2%)
5% - Benevolentai Bio Limited
7.2% - Industry AVG
Production
with a gross margin of 69.2%, this company has a lower cost of product (44.9%)
69.2% - Benevolentai Bio Limited
44.9% - Industry AVG
Profitability
an operating margin of -250.8% make it less profitable than the average company (5.7%)
-250.8% - Benevolentai Bio Limited
5.7% - Industry AVG
Employees
with 101 employees, this is above the industry average (23)
101 - Benevolentai Bio Limited
23 - Industry AVG
Pay Structure
on an average salary of £118.5k, the company has a higher pay structure (£53.9k)
£118.5k - Benevolentai Bio Limited
£53.9k - Industry AVG
Efficiency
resulting in sales per employee of £86.5k, this is less efficient (£125.8k)
£86.5k - Benevolentai Bio Limited
£125.8k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Benevolentai Bio Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 177 days, this is slower than average (31 days)
177 days - Benevolentai Bio Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Benevolentai Bio Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (24 weeks)
0 weeks - Benevolentai Bio Limited
24 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 498.1%, this is a higher level of debt than the average (53.3%)
498.1% - Benevolentai Bio Limited
53.3% - Industry AVG
BENEVOLENTAI BIO LIMITED financials
Benevolentai Bio Limited's latest turnover from December 2023 is £8.7 million and the company has net assets of -£55.8 million. According to their latest financial statements, Benevolentai Bio Limited has 101 employees and maintains cash reserves of £258 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 8,741,000 | 12,468,000 | 5,921,000 | 7,627,000 | 4,433,000 | 923,000 | 5,918,000 | 2,585,000 | 1,252,000 | 45,000 |
| Other Income Or Grants | ||||||||||
| Cost Of Sales | 2,691,000 | 1,543,000 | 37,000 | 45,000 | ||||||
| Gross Profit | 6,050,000 | 10,925,000 | 7,627,000 | 4,433,000 | 923,000 | 5,918,000 | 2,585,000 | 1,215,000 | ||
| Admin Expenses | 27,977,000 | 42,873,000 | 24,221,000 | 26,193,000 | 14,261,000 | 21,271,000 | 13,692,000 | 14,985,000 | 1,795,000 | |
| Operating Profit | -21,927,000 | -31,948,000 | -29,959,000 | -16,594,000 | -21,760,000 | -13,338,000 | -15,353,000 | -11,107,000 | -13,770,000 | -1,795,000 |
| Interest Payable | 4,000 | 9,000 | 1,000 | 15,000 | 1,000 | |||||
| Interest Receivable | 4,000 | 28,000 | 29,000 | 38,000 | 15,000 | 101,000 | 140,000 | 25,000 | ||
| Pre-Tax Profit | -21,927,000 | -31,957,000 | -29,959,000 | -16,567,000 | -21,746,000 | -13,303,000 | -15,335,000 | -11,006,000 | -13,789,000 | -1,770,000 |
| Tax | 3,557,000 | 6,638,000 | 4,823,000 | 4,066,000 | 5,098,000 | 3,938,000 | 2,679,000 | 1,962,000 | 1,036,000 | |
| Profit After Tax | -18,370,000 | -25,319,000 | -25,136,000 | -12,501,000 | -16,648,000 | -9,365,000 | -12,656,000 | -9,044,000 | -12,753,000 | -1,770,000 |
| Dividends Paid | ||||||||||
| Retained Profit | -18,370,000 | -25,319,000 | -25,136,000 | -12,501,000 | -16,648,000 | -9,365,000 | -12,656,000 | -9,044,000 | -12,753,000 | -1,770,000 |
| Employee Costs | 11,971,000 | 18,874,000 | 20,342,000 | 8,505,000 | 5,420,000 | 4,631,000 | 6,466,000 | 6,862,000 | 11,419,000 | 296,000 |
| Number Of Employees | 101 | 98 | 70 | 59 | 52 | 41 | 27 | 36 | 23 | 4 |
| EBITDA* | -21,925,000 | -31,936,000 | -29,932,000 | -15,558,000 | -20,851,000 | -13,230,000 | -15,353,000 | -10,993,000 | -13,760,000 | 8,074,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,892,000 | 1,895,000 | 2,399,000 | 2,427,000 | 2,582,000 | 4,256,000 | 4,224,000 | 8,900,000 | 355,000 | 74,000 |
| Intangible Assets | 836,000 | 904,000 | 949,000 | |||||||
| Investments & Other | 1,892,000 | 1,892,000 | 2,383,000 | 2,383,000 | 2,416,000 | 3,654,000 | 3,621,000 | 8,000,000 | 7,842,000 | |
| Debtors (Due After 1 year) | 450,000 | |||||||||
| Total Fixed Assets | 1,892,000 | 1,895,000 | 2,399,000 | 2,427,000 | 2,582,000 | 5,092,000 | 5,128,000 | 9,849,000 | 8,647,000 | 74,000 |
| Stock & work in progress | ||||||||||
| Trade Debtors | 794,000 | 26,600,000 | ||||||||
| Group Debtors | 3,235,000 | 2,543,000 | 389,000 | 1,060,000 | 66,000 | 38,757,000 | ||||
| Misc Debtors | 2,405,000 | 1,432,000 | 2,209,000 | 1,961,000 | 7,489,000 | 8,025,000 | 6,177,000 | 2,344,000 | 1,093,000 | 78,000 |
| Cash | 258,000 | 631,000 | 533,000 | 3,765,000 | 4,964,000 | 11,594,000 | 1,243,000 | 1,809,000 | 50,437,000 | 48,301,000 |
| misc current assets | ||||||||||
| total current assets | 12,115,000 | 12,038,000 | 8,044,000 | 11,115,000 | 12,519,000 | 20,413,000 | 34,020,000 | 42,910,000 | 51,530,000 | 48,379,000 |
| total assets | 14,007,000 | 13,933,000 | 10,443,000 | 13,542,000 | 15,101,000 | 25,505,000 | 39,148,000 | 52,759,000 | 60,177,000 | 48,453,000 |
| Bank overdraft | ||||||||||
| Bank loan | ||||||||||
| Trade Creditors | 1,305,000 | 2,324,000 | 998,000 | 961,000 | 1,903,000 | 4,549,000 | 2,725,000 | 554,000 | 245,000 | 229,000 |
| Group/Directors Accounts | ||||||||||
| other short term finances | ||||||||||
| hp & lease commitments | 88,000 | |||||||||
| other current liabilities | 68,431,000 | 50,316,000 | 32,705,000 | 19,301,000 | 9,823,000 | 675,000 | 585,000 | 3,293,000 | 3,121,000 | 2,940,000 |
| total current liabilities | 69,736,000 | 52,640,000 | 33,703,000 | 20,262,000 | 11,814,000 | 5,224,000 | 3,310,000 | 3,847,000 | 3,366,000 | 3,169,000 |
| loans | ||||||||||
| hp & lease commitments | ||||||||||
| Accruals and Deferred Income | 541,000 | 4,459,000 | 7,044,000 | |||||||
| other liabilities | ||||||||||
| provisions | 72,000 | 498,000 | 900,000 | 52,000 | 128,000 | |||||
| total long term liabilities | 36,000 | 249,000 | 450,000 | 26,000 | 541,000 | 4,523,000 | 7,044,000 | |||
| total liabilities | 69,772,000 | 52,889,000 | 34,153,000 | 20,262,000 | 11,814,000 | 5,250,000 | 3,851,000 | 8,370,000 | 10,410,000 | 3,169,000 |
| net assets | -55,765,000 | -38,956,000 | -23,710,000 | -6,720,000 | 3,287,000 | 20,255,000 | 35,297,000 | 44,389,000 | 49,767,000 | 45,284,000 |
| total shareholders funds | -55,765,000 | -38,956,000 | -23,710,000 | -6,720,000 | 3,287,000 | 20,255,000 | 35,297,000 | 44,389,000 | 49,767,000 | 45,284,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | -21,927,000 | -31,948,000 | -29,959,000 | -16,594,000 | -21,760,000 | -13,338,000 | -15,353,000 | -11,107,000 | -13,770,000 | -1,795,000 |
| Depreciation | 2,000 | 12,000 | 27,000 | 56,000 | 73,000 | 47,000 | 99,000 | 10,000 | 9,869,000 | |
| Amortisation | 980,000 | 836,000 | 61,000 | 15,000 | ||||||
| Tax | 3,557,000 | 6,638,000 | 4,823,000 | 4,066,000 | 5,098,000 | 3,938,000 | 2,679,000 | 1,962,000 | 1,036,000 | |
| Stock | ||||||||||
| Debtors | 1,665,000 | 1,377,000 | -423,000 | -4,534,000 | -1,264,000 | -23,958,000 | -8,324,000 | 39,558,000 | 1,465,000 | 78,000 |
| Creditors | -1,019,000 | 1,326,000 | 37,000 | -942,000 | -2,646,000 | 1,824,000 | 2,171,000 | 309,000 | 16,000 | 229,000 |
| Accruals and Deferred Income | 18,115,000 | 17,611,000 | 13,404,000 | 9,478,000 | 9,148,000 | -451,000 | -6,626,000 | -2,413,000 | 7,225,000 | 2,940,000 |
| Deferred Taxes & Provisions | -426,000 | -402,000 | 900,000 | -52,000 | 52,000 | -128,000 | 128,000 | |||
| Cash flow from operations | -3,363,000 | -8,140,000 | -10,345,000 | 1,578,000 | -8,039,000 | 16,091,000 | -50,565,000 | -6,948,000 | 11,165,000 | |
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | -491,000 | -33,000 | -1,238,000 | 33,000 | -4,379,000 | 158,000 | 7,842,000 | |||
| cash flow from investments | -7,842,000 | |||||||||
| Financing Activities | ||||||||||
| Bank loans | ||||||||||
| Group/Directors Accounts | ||||||||||
| Other Short Term Loans | ||||||||||
| Long term loans | ||||||||||
| Hire Purchase and Lease Commitments | -88,000 | 88,000 | ||||||||
| other long term liabilities | ||||||||||
| share issue | ||||||||||
| interest | -9,000 | 27,000 | 14,000 | 38,000 | 15,000 | 101,000 | 139,000 | 25,000 | ||
| cash flow from financing | 1,561,000 | 10,064,000 | 8,146,000 | 2,433,000 | -218,000 | -5,639,000 | 3,579,000 | 3,767,000 | 17,375,000 | 47,079,000 |
| cash and cash equivalents | ||||||||||
| cash | -373,000 | 98,000 | -3,232,000 | -1,199,000 | -6,630,000 | 10,351,000 | -566,000 | -48,628,000 | 2,136,000 | 48,301,000 |
| overdraft | ||||||||||
| change in cash | -373,000 | 98,000 | -3,232,000 | -1,199,000 | -6,630,000 | 10,351,000 | -566,000 | -48,628,000 | 2,136,000 | 48,301,000 |
benevolentai bio limited Credit Report and Business Information
Benevolentai Bio Limited Competitor Analysis
Perform a competitor analysis for benevolentai bio limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in W1T area or any other competitors across 12 key performance metrics.
benevolentai bio limited Ownership
BENEVOLENTAI BIO LIMITED group structure
Benevolentai Bio Limited has 1 subsidiary company.
Ultimate parent company
BENEVOLENTAI
#0054916
2 parents
BENEVOLENTAI BIO LIMITED
08774096
1 subsidiary
benevolentai bio limited directors
Benevolentai Bio Limited currently has 4 directors. The longest serving directors include Mr Tom Holgate (May 2019) and Baroness Joanna Shields (May 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Tom Holgate | United Kingdom | 47 years | May 2019 | - | Director |
| Baroness Joanna Shields | England | 62 years | May 2019 | - | Director |
| Dr Ivan Griffin | United Kingdom | 48 years | May 2019 | - | Director |
| Mr Michael Brennan | United Kingdom | 53 years | Jan 2025 | - | Director |
P&L
December 2023turnover
8.7m
-30%
operating profit
-21.9m
-31%
gross margin
69.3%
-21.01%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-55.8m
+0.43%
total assets
14m
+0.01%
cash
258k
-0.59%
net assets
Total assets minus all liabilities
Similar Companies
benevolentai bio limited company details
company number
08774096
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
November 2013
age
12
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
stratified medical limited (August 2016)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
4-8 maple street, london, W1T 5HD
Bank
-
Legal Advisor
-
benevolentai bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to benevolentai bio limited.
benevolentai bio limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BENEVOLENTAI BIO LIMITED. This can take several minutes, an email will notify you when this has completed.
benevolentai bio limited Companies House Filings - See Documents
| date | description | view/download |
|---|
